This article provides an overview of natural products with pro-oxidant and anticancer activities, with a special focus on plant secondary metabolites, and discusses their possible use as cancer chemotherapeutic agents.
Martín-Co et al., 2012
Noscapine, an antitumor alkaloid obtained from opium poppy, bound to tubulin, arrested metaphase, and induced apoptosis in dividing human cells. Winzer et al., 2012 Preclinical evidence suggests that plant phytoalexins possess anticancer properties. Romagnolo et al., 2012 Sulforaphane, a compound derived from cruciferous plants displayed anticancer properties in human prostate cancer cell lines and in xenograft animal models. Wiczk et al., 2012 Luteolin inhibited hypoxia-induced epithelial mesenchymal transition in cultured human non-small cell lung cancer cells. Ruan et al., 2012 Secondary metabolites of plants, such as alkaloids, phenolics, and terpenoids reversed drug resistance in cancer cells and microbes by interfering with ATP-binding cassette transporters. Wink et al., 2012 Betulinic acid killed melanoma, leukemia, lung, colon, breast, prostate and ovarian cancer cells via induction of apoptosis. Liu and Luo, 2012 Lunasin, a peptide derived from the soybean 2S albumin seed protein, demonstrated both anticancer and anti-inflammatory activity. Seber et al., 2012 Plumbagin, a constituent of species of the plant genera Drosera and Plumbago, displayed antineoplastic activity toward various cancers. Kawiak et al., 2012 
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Gallic acid-based steroidal phenstatin analogues exhibited significant anticancer activity against breast cancer cell lines by through inhibiting tubulin polymerization.
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Cryptotanshinone induced caspase-independent cell death in human tumor cells.
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Ursolic acid exhibited potent anticancer activity against many types of cancer cells. It elicited strong antitumor effects via upregulation of the PTEN gene and inhibition of the PI3K/Akt pathway.
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Coumarins and its derivatives with potent in vitro/in vivo biological activity were implicated as promising anticancer compounds.
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Recent advances in the discovery and evaluation of ginsenosides as anticancer agents support further pre-clinical and clinical development of these agents for the treatment of primary and metastatic tumors.
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Withanolides, a large group of steroidal lactones found in Solanaceae plants, exhibited potential anticancer activity.
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Weekly administration of paclitaxel-carboplatin had limited clinical benefit in the treatment of vulvar squamous cell carcinoma.
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Carnosic acid, the main antioxidant compound of Rosmarinus officinalis L., inhibited the proliferation and migration capacity of human colorectal cancer cells.
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Pomolic acid used as an anti-cancer agent in the treatment of breast cancer, modulated AMP-activated protein kinase pathways.
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The development of leads from 1,4-naphthoquinones obtained from Diospyros L. are growing dramatically, especially in anticancer and antibacterial investigations.
Nematollahi et al., 2012
4-Shogaol, an active constituent of dietary ginger, may be a novel anticancer agent for the treatment of metastasis in breast cancer.
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Sanguinarine, a benzophenanthridine alkaloid, induced apoptosis in HT-29 human colon cancer cells and may have a potential therapeutic use in the treatment of human colon cancer.
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The ability of α-mangostin, a xanthone from the mangosteen fruit, to inhibit prostate cancer in vitro and in vivo suggested that it may be a novel agent for the management of prostate cancer. Johnson et al., 2012 Magnolol is a promising natural compound for the treatment of gastric cancer and may be a potential candidate for in vivo studies of monotherapies or combination antitumor therapies. Rasul et al., 2012 
